Purchase Order 75N93018P00674

The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $12,235.00 firm-fixed-price purchase order contract to Horizon Discovery Limited, a for-profit biotechnology company based in the United Kingdom. The contract is for the provision of custom human cell lines to support biomedical research, with a completion date of December 13, 2019. No set-aside was used for this award. Horizon Discovery...

This firm fixed-price purchase order was awarded by the National Institute of Child Health and Human Development (NICHD), a component of the National Institutes of Health (NIH), to Horizon Discovery Limited, a UK-based biotechnology company, for whole-genome CRISPR knockout gene interaction screening services. The contract, valued at $92,500, was awarded in support of NICHD research to translate genomic and genetic research into a greater understanding of human genetic disease and the...

This federal contract award to Horizon Discovery Biosciences LIMITED, a foreign-owned for-profit manufacturer, is for the delivery of small interfering RNA (siRNA) genome libraries. These specialized genetic research materials will be used by the Defense Health Agency to evaluate experimental systems. The $71,463.99 firm fixed-price purchase order does not have a set-aside designation, reflecting Horizon Discovery Biosciences' status as a large business. The parent company, Revvity Inc., is a...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $30,316.20 firm fixed price purchase order to Horizon Discovery Biosciences Limited, located in Great Britain, United Kingdom. The contract is for unspecified products or services to be delivered between July 12, 2023 and July 22, 2023 in support of NIH's efforts to enhance the development, testing, and implementation of translational sciences. Horizon...

The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $20,830.00 firm-fixed-price purchase order to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, for the provision of PATHHUNTER CHO-K1 DRD3 ARRESTIN CELL LINE and U2OS DRD3 ARRESTIN CELL LINE. This award is not associated with any set-aside program. Eurofins Discoverx Corporation is a leading provider of innovative cell-based assays...

This firm fixed-price purchase order for $18,204.88 was awarded by the Department of Health and Human Services' National Institutes of Health National Institute on Drug Abuse to Genscript USA Inc. to obtain cell lines utilizing CRISPR gene editing technology. Specifically, the contract calls for Genscript to generate knockout HEK293 and HepG2 cell lines of the MMAB and MUT genes to support studies for hereditary disorders of vitamin B12 and methylmalonic acid metabolism. No set-aside designation...

This is a firm fixed-price purchase order contract awarded by the National Institute of Child Health and Human Development (NICHD), a component of the U.S. Department of Health and Human Services, to Genscript USA Inc., a biotechnology company based in Piscataway, New Jersey. The contract, valued at $21,277.24, is for the generation of a POLH/POLI knockout MRC5SV cell line and other associated services. The contract does not have a set-aside designation. Genscript is a well-established...

The National Heart Lung and Blood Institute, a civilian federal agency, awarded a $11,450.00 firm-fixed-price purchase order to Editco Bio Inc., a self-certified small disadvantaged business, to provide knock-in cell line generation services to support Dr. Martina's cell biology experiments. The contract has an ultimate completion date of December 26, 2024 and was awarded on August 29, 2024. This contract award is not associated with a larger vehicle and does not have a set-aside designation.

The National Heart Lung and Blood Institute (NHLBI), a civilian agency within the National Institutes of Health (NIH), awarded a $17,000.00 firm fixed-price purchase order to Synthego Corporation, a self-certified small disadvantaged business and manufacturer of gene editing products. The contract is for knock-out cell line generation services to support the agency's cell biology experiments. No set-aside designation was used. Synthego, a leading provider of advanced genetic engineering tools...

This is a firm fixed-price purchase order awarded by the National Institute of Child Health and Human Development (NICHD) to Cyagen US Inc., a biotechnology company specializing in knockout and transgenic mouse models. The $97,577 contract is for Cyagen to provide "TurboKnockout" mouse gene targeting services to support biomedical research projects funded by NICHD. The contract has a completion date of June 22, 2021 and was awarded on a sole-source basis, as Cyagen's proprietary...